UBS Boosts Price Target, Estimates on Aetna (AET)

Due to its recent acquisition of Coventry Health and a reduction in its debt-to-capital ratio, analysts at UBS raised the price target and earnings estimates on health care benefits company Aetna Inc. (AET) on Wednesday.

The analysts see shares of AET reaching $68, which suggests a 15% upside to Tuesday’s closing price of $59.07.

Aetna shares were inactive during pre-market trading on Wednesday. The stock is up +27.55% year-to-date.

The Bottom Line
Shares of Aetna (AET) have a dividend yield of 1.35% based on last night’s closing price of $59.07 and the company’s annualized dividend payout of 80 cents per share.

Aetna Inc. (AET) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here